Based on the literature, both receptors have no significant structural differences, and in various neoplasms, the dominant mechanism of apoptosis induction may be more related to TRAIL-R1, whereas in others, instead to TRAIL-R2. This evidence concerns the gene TNFRSF10B and neoplasm.